View Post Risk of Chronic Kidney Disease in People Living with HIV by Tenofovir Disoproxil Fumarate (TDF) Use and Baseline D:A:D Chronic Kidney Disease Risk Score. HIV Medicine, 22(5): 325-333. In by AHFNovember 1, 2020
View Post Efficacy, Safety, and Tolerability of Etravirine With and Without Darunavir/Ritonavir or Raltegravir in Treatment-Experienced Patients: Analysis of the Etravirine Early Access Program in the United States. Journal of Acquired Immune Deficiency Syndrome, 53(5): 614-618. In by AHFApril 1, 2010
View Post Maraviroc for Previously Treated Patients with R5 HIV-1 Infection. The New England Journal of Medicine, 359: 1429-1441. In by AHFOctober 1, 2008
View Post Pancreatitis Treated with Didanosine and Tenofovir Disoproxil Fumarate. Clinical Infectious Diseases, 37(5): e57-e62. In by AHFSeptember 1, 2003
